\
&
Contact us
\
&
Contact us
Published on | 3 months ago
ProgrammesOn 10 December, the European Partnership for Personalised Medicine (EP PerMed) will launch its Twinning Call, aiming to accelerate the implementation of personalised medicine (PM) solutions or approaches from one country to another through structured peer-to-peer exchanges.
What is Twinning?A Twinning partnership connects a Twinning Donor—an organisation with an innovative PM solution or approach—with a Twinning Receiver seeking to adopt and implement that solution.
The call offers up to €50,000 for activities that enable this exchange and strengthen capabilities on both sides. Twinning projects should run for 6 to 12 months.
The Twinning Partnerships are aimed in particular at local, regional and national health and care providers legally registered in an EU Member State or a Horizon Europe associated country that wish to adopt PM solutions that are transferable from one provider to another.
Currently, an Early Matchmaking phase is underway to help potential Twinning Donors and Receivers connect, share ideas, and start shaping proposals. Join the Matchmaking Platform here (open until 26 February 2026).
On 17 December, EP PerMed is organising an info webinar on the upcoming call. Register here.
On 15 January, EP PerMed is organising an online Matchmaking event where Twinning Donors and Receiver organisations can present their succesful PM approaches or needs in the form of a pitch. Register here.
More information on the Twinning call can be found on the EP PerMed website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
